Asuragen, Novartis Team on RT-qPCR Tools | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Asuragen today said that it has entered into an exclusive collaboration with Novartis to develop tools intended to aid laboratories with standardization of BCR-ABL1 RT-qPCR testing to the international scale.

The Austin, Texas-based firm said that it would distribute the Armored RNA Quant BCR-ABL1 RNA International Scale calibrators and software reporting tools directly or through distributors worldwide.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.